Acrivon Therapeutics Company Insiders

Acrivon Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.3089) % which means that it has lost $0.3089 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5023) %, meaning that it created substantial loss on money invested by shareholders. Acrivon Therapeutics' management efficiency ratios could be used to measure how well Acrivon Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.39 in 2026. Return On Capital Employed is likely to drop to -0.47 in 2026. At this time, Acrivon Therapeutics' Net Tangible Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 17.4 M in 2026, whereas Other Assets are likely to drop 0.86 in 2026. Common Stock Shares Outstanding is likely to drop to about 23.8 M in 2026. Net Loss is likely to drop to about (29.5 M) in 2026Acrivon Therapeutics holds a total of 31.56 Million outstanding shares. Over half of Acrivon Therapeutics' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Acrivon Therapeutics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Acrivon Therapeutics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Acrivon Therapeutics Workforce Comparison

Acrivon Therapeutics Insider Trading History

Acrivon Therapeutics Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Acrivon Therapeutics often depends on how effective the management is. Acrivon Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Acrivon management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Acrivon management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Acrivon Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Acrivon Therapeutics Common. Check Acrivon Therapeutics' Beneish M Score to see the likelihood of Acrivon Therapeutics' management manipulating its earnings.

When running Acrivon Therapeutics' price analysis, check to measure Acrivon Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics is operating at the current time. Most of Acrivon Therapeutics' value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics' price. Additionally, you may evaluate how the addition of Acrivon Therapeutics to your portfolios can decrease your overall portfolio volatility.